Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Optimizing treatment for heart attack using advanced techniques

Official title: The STEMI Optimization Trial - Ischemic Postconditioning (DANAMI4-iPOST) and Intravascular Ultrasound Guided PCI in STEMI (DANAMI4-iSTEMI)

Run by Copenhagen University Hospital, Rigshospitalet · NCT04775914 · Data updated 2026-11-12

This study is testing if a new way of treating heart attacks using special techniques can help people with severe chest pain recover better than the usual treatment.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment2500 (estimated)
SponsorCopenhagen University Hospital, Rigshospitalet
Academic / other
Locations1 site (Copenhagen, Capital Region)
StatusRecruiting
StartedApril 1, 2021
Main results expectedFebruary 1, 2027
Study endsFebruary 1, 2031
Registry record updatedMarch 30, 2026
Trial IDNCT04775914 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who present with acute chest pain and meet specific criteria for STEMI.

Probably not a fit

Patients with a pre-PCI TIMI flow of 0 or 1, those who are pregnant, or individuals unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of ischemic postconditioning (iPOST) combined with intravascular ultrasound (IVUS) guidance during percutaneous coronary intervention (PCI) for patients experiencing ST-segment elevation myocardial infarction (STEMI). The goal is to determine if these advanced techniques can improve clinical outcomes compared to standard PCI methods. Patients with acute chest pain and specific ST elevation criteria will be enrolled, and their treatment will be closely monitored to assess the benefits of the intervention.

Why it matters

Potential benefit: If successful, this approach could lead to better recovery outcomes for patients suffering from heart attacks.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving outcomes for heart attack patients using advanced PCI techniques.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* Acute onset of chest pain with \<12 hours duration
* STEMI as characterized by 2 mm ST elevation in 2 or more V1 through V4 leads or presumed new left bundle branch block with minimum of 1 mm concordant ST elevation or 1 mV ST-segment elevation in the limb lead (II, III and aVF, I, aVL) and V4-V6 or ST depression in 2 or more V1 through V4 leads indicating posterior AMI.

Exclusion Criteria (iPOST2):

Pre-PCI TIMI flow 0 or 1 Potential pregnancy Inability to provide informed consent Unwillingness to consent Unavoidable to use thrombectomy Spontaneous coronary artery dissection Time from symptoms onset to PPCI \> 12 hours Culprit in bypass graft Other reason for not including the patient

Exclusion Criteria (iSTEMI):

Potential pregnancy Inability to understand information in order to provide informed consent Unwillingness to consent Spontaneous coronary artery dissection Time from symptoms inset to PPCI \> 12 hours Culprit in bypass graft Other reason

Where it's running

  • Heart Center, Rigshospitalet
    Copenhagen, Capital Region, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.